Skip to content

Prospective clinical study on optical navigation assisted ultrasound-guidedsclerotherapy for cysts

Prospective clinical study on optical navigation assisted ultrasound-guidedsclerotherapy for cysts

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110997
Enrollment
Unknown
Registered
2025-10-23
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cyst, Liver/kidney cyst

Interventions

Experimental group:Optical navigation

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Thyroid cyst: 1) Diagnosed by ultrasound as a simple thyroid cyst with a maximum diameter of >= 2cm; 2) Has nodule related pain, compression symptoms, or (and) affects aesthetics; 3) Refuse to continue observation or surgery, voluntarily sign an informed consent form, understand the treatment plan and potential risks. 2.Liver/kidney cyst: 1) The maximum diameter of liver and kidney cysts is >= 5cm; 2) Patients with cysts accompanied by bleeding and/or infection; 3) Patients with cysts accompanied by compression and other symptoms; 4) Polycystic liver and polycystic kidney cysts causing compression symptoms; 5) Refuse to continue observation or surgery, voluntarily sign an informed consent form, understand the treatment plan and potential risks.

Exclusion criteria

Exclusion criteria: 1.Thyroid cyst: 1) Known or suspected thyroid cancer; 2) Severe heart and lung dysfunction, liver and kidney failure, or immune system diseases; 3) Coagulation dysfunction or recent use of anticoagulant drugs; 4) Allergic to hardening agents such as polyglycol; 5) The patient refused to cooperate. 2.Liver/kidney cyst: 1) Renal pelvis derived cyst connected to the ureter; 2) Congenital cystic dilation of intrahepatic bile ducts or hepatic cysts connected to intrahepatic bile ducts; 3) Individuals with allergies to polyols and alcohol; 4) Individuals with severe cardiovascular and cerebrovascular diseases, severe mental disorders, poor compliance, and inability to tolerate treatment; 5) Patients with bleeding tendency and coagulation dysfunction during anticoagulant therapy; 6) There is no safe puncture path to avoid important blood vessels, bile ducts, and structures.

Design outcomes

Primary

MeasureTime frame
Volume reduction rate;

Secondary

MeasureTime frame
Total surgical time;The confidence score of the interventional doctor's operation;Comfort rating of equipment;Patient complications;

Countries

China

Contacts

Public ContactZhang Mingbo

Chinese PLA General Hospital

owsifanduizhe@126.com+86 135 5274 4805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026